Thank you, Jay. I will provide a brief overview of Nortech's financial performance for the second quarter ended June 30, 2026. Additional details are available in our Form 8-K earnings release and Form 10-Q filed with the Securities and Exchange Commission this afternoon. As we have discussed previously, quarterly results can be influenced by the timing of customer shipments, production schedules and working capital movements. While those factors persist, our execution and longer-term strategies are gaining traction as we move through 2026, consistent with Jay's comments earlier in the call. Net sales for the second quarter of 2026 were $33.5 million, an increase of $2.9 million or 9.3% compared with $30.7 million in the second quarter of 2025. Growth was led by the medical device market, where sales increased 36% year-over-year, primarily due to higher customer demand from existing customers and continued ramp-up of new programs. Medical imaging sales increased 12.2%, driven by higher customer demand supported in part by increased revenues from a stocking program with a key customer that provides product availability to enable shorter lead times. Industrial sales decreased 4.7%, reflecting customer inventory adjustments and temporary production disruptions associated with the transfer of manufacturing activities to Monterrey, Mexico, partially offset by growth in China. Aerospace and Defense sales decreased 12.8% in the quarter, primarily due to reduced demand from one customer who is reducing post-COVID inventory levels. However, year-to-date aerospace and defense sales increased 8.7% compared with the prior year period, benefiting from higher production volumes associated with completed transfers to our Bemidji location. Gross profit totaled $5.7 million compared with $4.8 million in the prior year period and gross margin improved to 17% up 120 basis points compared with 15.8% last year. The improvement was primarily attributable to higher revenue levels and improved manufacturing cost absorption resulting from increased production activity, partially offset by unfavorable sales mix. Total operating expenses were $5.1 million in the second quarter of 2026 compared with $4.1 million in the prior year period. The increase in operating expenses was primarily attributable to higher incentive compensation accruals in 2026. For the 3 and 6 months ended June 30, 2026, incentive compensation expenses were $402,000 and $647,000, respectively, compared with a reversal of expense of $131,000 during the second quarter of 2025 resulting in no management incentive compensation recorded in the first half of 2025. In summary, incentive compensation expense in the second quarter and year-to-date periods in 2026 were $533,000 and $647,000 higher than in the respective 2025 periods. As a result, we reported second quarter operating income of $623,000 compared with operating income of $742,000 in the prior year period. For the 6 months -- for the first 6 months of 2026, operating income was $670,000 compared with an operating loss of $871,000 in the same prior year period, reflecting higher gross profit associated with increased revenue and improved operating leverage, offset by higher management incentive compensation, together with the absence of a $266,000 restructuring charge recorded in the first quarter of 2025. Net interest expense was $197,000 compared with $257,000 last year during the quarter, driven by lower average borrowings and reduced interest costs following the transition to our new financing arrangements. We reported second quarter net income of $316,000 or $0.11 per diluted share compared with net income of $313,000 or $0.12 per diluted share in the second quarter of 2025. For the first 6 months of 2026, net income was $282,000 or $0.09 per share compared with a net loss of $1 million or $0.36 per share in the same prior period. Cash used in operating activities was $2.4 million in the first 6 months of 2026 compared with $2.8 million in the prior year period. Cash used by accounts receivable and contract assets was $4.5 million, largely due to the timing of customer shipments and related cash collections and an increase in our contract assets to support future customer shipments. Cash used by inventory was $3.5 million, reflecting purchases of materials needed to support the growing backlog. These uses of cash were partially offset by $2.1 million of cash provided by changes in accounts payable, primarily related to the timing of cash payments. At quarter end, cash and restricted cash totaled $1.7 million. Under our Associated Bank facility, the revolving credit facility balance was $7.6 million, and we had $3.6 million of unused availability as of June 30, 2026. For the remainder of the year, with the support of our recently hired Vice President of Supply Chain, we are very focused on reducing investments in inventory and generating cash from reductions in working capital, while year-over-year revenue growth, improved gross margins, positive year-to-date operating income and a more flexible capital structure, we believe that Nortech is well positioned to continue building momentum throughout the year. With that, I will turn it back to Jay for his closing remarks. Jay?